SphereBio
SphereBio develops biotech platforms that deliver molecules to cells, training them to generate specific responses to health issues.
Operating in biotechnology, oncology, therapeutics, SphereBio was founded in 2023.
The company sits in the biotechnology, oncology, therapeutics segment, where it competes on its core product or service.
It is recorded at the Private company stage.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Oncology, Therapeutics |
|---|---|
| Founded | 2023 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.spherebio.co
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account